• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Avian Pathol . In Vitro Antiviral Activity of NanB Bacterial Sialidase Against Avian Influenza H9N2 Virus in MDCK cells

tetano

Editor, Senior Moderator
Avian Pathol


. 2024 Jul 29:1-24.
doi: 10.1080/03079457.2024.2386315. Online ahead of print. In Vitro Antiviral Activity of NanB Bacterial Sialidase Against Avian Influenza H9N2 Virus in MDCK cells

Christian Marco Hadi Nugroho[SUP] 1 2 [/SUP], Otto Sahat Martua Silaen[SUP] 1 [/SUP], Ryan Septa Kurnia[SUP] 1 2 [/SUP], Desak Gede Budi Krisnamurti[SUP] 3 [/SUP], Muhammad Ade Putra[SUP] 4 [/SUP], Agustin Indrawati[SUP] 4 [/SUP], Okti Nadia Poetri[SUP] 4 [/SUP], I Wayan Teguh Wibawan[SUP] 4 [/SUP], Silvia Tri Widyaningtyas[SUP] 5 [/SUP], Amin Soebandrio[SUP] 6 [/SUP]



Affiliations
Abstract

AbstractThe Avian influenza virus is an infectious agent that may cause global health problem issues in poultry and potentially zoonotic. In recent decades, bacterial-derived sialidases have been extensively studied for their ability to inhibit avian influenza virus infections. In this study the antiviral activity of NanB sialidase from Pasteurella multocida was investigated through in vitro analysis using MDCK cells. NanB sialidase was purified from P. multocida for testing its toxicity and its ability to hydrolyze its sialic acid receptors on MDCK cells. H9N2 challenge virus was propagated in MDCK cells until cytopathic effects (CPE) appeared. Antiviral activity of NanB sialidase was conducted using MDCK cells, and then observed based on cell morphology, viral copy number, and expression of apoptosis-mediating genes. NanB sialidase effectively hydrolyzes Neu5Acα(2-6)Gal sialic acid at the dose of 129 mU/ml, while at 258 mU/ml it cause toxicity on MDCK cells. Antiviral activity of sialidase is evident based on the significantly decrease in viral copy number at all doses administrated. The increase of p53 and caspase-3 expression was observed in infected cells without sialidase. Our study demonstrates the ability of NanB sialidase to inhibit H9N2 virus replication based on observations of sialic acid hydrolysis, reduction in viral copy number, and expression of apoptosis-related genes. The future application of sialidase may be considered as an antiviral strategy against avian influenza H9N2 virus infections.

Keywords: Antiviral; Avian influenza; NanB; Neu5Acα(2-6)Gal; Pasteurella multocida; Sialidase.

 
Back
Top Bottom